U.S. Market Projected to Hit USD 7.06 Billion by 2035 While Europe Market Expected to Reach USD 6.42 Billion as Aging Male Population Fuels Demand for Advanced BPH Therapies.Austin, United States, May ...
Struggling with BPH symptoms? Explore UroLift, a patient-friendly, day-care prostate treatment that avoids major surgery and ...
MedPage Today on MSN
Temporary prostatic urethra expander for BPH/LUTS shows durable results
Study showed immediate improvement in symptoms after intentional retrieval of device at 6 ...
Baptist Health System now offers aquablation therapy for men with benign prostatic hyperplasia or BPH, a health issue that becomes more common with age. The advertiser paid a fee to promote this ...
Data Supported the FDA Approval of the Zenflow Spring® Implant and Delivery System for BPHAdditional presented data highlights patient ...
Andera Partners said today that it led a $20 million Series D financing round for urology-focused medical device maker ...
Butterfly Medical announced today that it completed its Series C funding round, bringing in $21 million to support its BPH ...
An enlarged prostate is a condition that most commonly affects men over 50, but it can begin once you reach your 30s. This condition, often called benign prostatic hyperplasia or BPH, is non-cancerous ...
Sumitomo Pharma America, Inc. (SMPA) today announced the presentation of new data from its urology and oncology portfolios at the American Urological Association (AUA) 2026 Annual Meeting, held on May ...
Today, the American Urological Association (AUA) released the 2026 Management of Lower Urinary Tract Symptoms (LUTS) Attributed to Benign Prostatic Hyperplasia (BPH) Guideline, providing updated, ...
Multiple studies have investigated associations of BPH and/or lower urinary tract symptoms (LUTS) with metabolic syndrome as a whole and its components, for example visceral obesity, glucose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results